About the Center
The Center for Alzheimer’s and Neurodegenerative Diseases (CAND) integrates cross-disciplinary clinical, research, and educational programs to advance precision diagnosis and personalized therapies for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions.
The challenge of neurodegeneration requires innovative strategies informed by multiple scientific and medical disciplines. Our mission is to dissect the unique interactions between genes, lifestyle and other factors that trigger Alzheimer’s and other forms of neurodegeneration in each person. These insights promise groundbreaking improvements for risk prediction and more personalized, targeted therapies.
Our faculty, trainees, and staff draw from many outstanding Baylor College of Medicine departments and centers, and we are also collaborating with colleagues in Houston and around the world. CAND-supported research and educational resources will propel breakthrough discoveries and accelerate translation for clinical care. We are also engaging with community partners to increase awareness and tackle neurodegeneration together.
View a message from Joshua M. Shulman, M.D., Ph.D., director of the Center for Alzheimer’s and Neurodegenerative Disease.
Seminars and Meetings
Cross-Disciplinary Alzheimer’s Consensus Research Conference: Clinicians and researchers unite to learn about the latest advances.
Computational Collaborative: Innovative working group to promote translation from basic discoveries to human applications.
Access CAND data, biospecimens, expertise, and pilot funding to accelerate breakthroughs in neurodegeneration.
Opportunities for tomorrow’s neurodegeneration-focused physicians and scientists, including the CAND Scholars program.
CAND physicians and scientists are reimagining the pipeline from basic discovery through neurological care with a view toward more individualized therapies.
Unparalleled, multidisciplinary clinical care for patients and families affected by neurodegenerative diseases.